Exhibit 32.2

                            CERTIFICATION PURSUANT TO

                             18 U.S.C. SECTION 1350,

                             AS ADOPTED PURSUANT BY

SECTION 906 OF THE  SARBANES-OXLEY  ACT OF 2002 In connection with the Quarterly
Report of Evolve Oncology,  Inc., on Form 10-QSB for the period ending March 31,
2005 as filed with the  Securities  and Exchange  Commission  on the date hereof
(the  "Report" ), the  undersigned,  Alan  Bowen,  Chief  Financial  Officer and
Principal  Accounting  Officer of the  Company,  certify,  pursuant to 18 U.S.C.
1350, as adopted pursuant to ss. 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the  requirements of section 13 (a) or 15 (d)
of the Securities Exchange Act of 1934; and

(2) The  information  contained in the Report fairly  presents,  in all material
respects, the financial condition and result of operations of the Company.


Date: November 18, 2005

By: /s/ Alan Bowen
- ------------------------------------
Alan Bowen
CFO
(Principal Financial Officer)


A signed  original of this written  statement  required by Section 906, or other
document authenticating, acknowledging, or otherwise adopting the signature that
appears in typed form within the  electronic  version of this written  statement
has been  provided  to the  Company  and will be  retained  by the  Company  and
furnished to the Securities and Exchange Commission or its staff upon request.